Report Detail

Pharma & Healthcare Global Intravenous Immunoglobulin (IVIg) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2974985
  • |
  • 18 February, 2019
  • |
  • Global
  • |
  • 120 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

Scope of the Report:
North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), enjoying production market share nearly 23% in 2016.
North America is the largest sales place, with a sales market share nearly 44% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 22%.
Market competition is intense. Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Intravenous Immunoglobulin (IVIg) is expected to grow at a CAGR of roughly 6.0% over the next five years, will reach 11500 million US$ in 2024, from 8120 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Intravenous Immunoglobulin (IVIg) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
IVIg Liquid
IVIg Powder

Market Segment by Applications, can be divided into
Immunodeficiency
Autoimmune Disease
Acute Infection

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous Immunoglobulin (IVIg) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravenous Immunoglobulin (IVIg), with price, sales, revenue and global market share of Intravenous Immunoglobulin (IVIg) in 2017 and 2018.
Chapter 3, the Intravenous Immunoglobulin (IVIg) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Immunoglobulin (IVIg) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Intravenous Immunoglobulin (IVIg) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Intravenous Immunoglobulin (IVIg) sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Intravenous Immunoglobulin (IVIg) Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 IVIg Liquid
      • 1.2.2 IVIg Powder
    • 1.3 Market Analysis by Applications
      • 1.3.1 Immunodeficiency
      • 1.3.2 Autoimmune Disease
      • 1.3.3 Acute Infection
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Baxter
      • 2.1.1 Business Overview
      • 2.1.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Grifols
      • 2.2.1 Business Overview
      • 2.2.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 CSL
      • 2.3.1 Business Overview
      • 2.3.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Octapharma
      • 2.4.1 Business Overview
      • 2.4.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Biotest
      • 2.5.1 Business Overview
      • 2.5.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Kedrion
      • 2.6.1 Business Overview
      • 2.6.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Hualan Bio
      • 2.7.1 Business Overview
      • 2.7.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 CNBG
      • 2.8.1 Business Overview
      • 2.8.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Shanghai RAAS
      • 2.9.1 Business Overview
      • 2.9.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 CBPO
      • 2.10.1 Business Overview
      • 2.10.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 LFB Group
      • 2.11.1 Business Overview
      • 2.11.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 BPL
      • 2.12.1 Business Overview
      • 2.12.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Sichuan Yuanda Shuyang
      • 2.13.1 Business Overview
      • 2.13.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Intravenous Immunoglobulin (IVIg) Market Analysis by Regions

    • 4.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 4.3 Europe Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 4.5 South America Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)

    5 North America Intravenous Immunoglobulin (IVIg) by Country

    • 5.1 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Country
      • 5.1.1 North America Intravenous Immunoglobulin (IVIg) Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 5.3 Canada Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)

    6 Europe Intravenous Immunoglobulin (IVIg) by Country

    • 6.1 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 6.3 UK Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 6.4 France Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 6.5 Russia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 6.6 Italy Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Intravenous Immunoglobulin (IVIg) by Country

    • 7.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Country (2014-2019)
    • 7.2 China Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 7.3 Japan Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 7.4 Korea Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 7.5 India Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)

    8 South America Intravenous Immunoglobulin (IVIg) by Country

    • 8.1 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Country
      • 8.1.1 South America Intravenous Immunoglobulin (IVIg) Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Intravenous Immunoglobulin (IVIg) by Countries

    • 9.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2014-2019)

    10 Global Intravenous Immunoglobulin (IVIg) Market Segment by Type

    • 10.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2014-2019)
    • 10.2 IVIg Liquid Sales Growth and Price
      • 10.2.1 Global IVIg Liquid Sales Growth (2014-2019)
      • 10.2.2 Global IVIg Liquid Price (2014-2019)
    • 10.3 IVIg Powder Sales Growth and Price
      • 10.3.1 Global IVIg Powder Sales Growth (2014-2019)
      • 10.3.2 Global IVIg Powder Price (2014-2019)

    11 Global Intravenous Immunoglobulin (IVIg) Market Segment by Application

    • 11.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2014-2019)
    • 11.2 Immunodeficiency Sales Growth (2014-2019)
    • 11.3 Autoimmune Disease Sales Growth (2014-2019)
    • 11.4 Acute Infection Sales Growth (2014-2019)

    12 Intravenous Immunoglobulin (IVIg) Market Forecast (2019-2024)

    • 12.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Intravenous Immunoglobulin (IVIg) Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Intravenous Immunoglobulin (IVIg) Market Forecast (2019-2024)
      • 12.2.2 Europe Intravenous Immunoglobulin (IVIg) Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Forecast (2019-2024)
      • 12.2.4 South America Intravenous Immunoglobulin (IVIg) Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Forecast (2019-2024)
    • 12.3 Intravenous Immunoglobulin (IVIg) Market Forecast by Type (2019-2024)
      • 12.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Intravenous Immunoglobulin (IVIg) Market Share Forecast by Type (2019-2024)
    • 12.4 Intravenous Immunoglobulin (IVIg) Market Forecast by Application (2019-2024)
      • 12.4.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Intravenous Immunoglobulin (IVIg) Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Intravenous Immunoglobulin (IVIg) . Industry analysis & Market Report on Intravenous Immunoglobulin (IVIg) is a syndicated market report, published as Global Intravenous Immunoglobulin (IVIg) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Intravenous Immunoglobulin (IVIg) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,777.04
      4,165.56
      5,554.08
      3,246.84
      4,870.26
      6,493.68
      535,084.80
      802,627.20
      1,070,169.60
      290,440.80
      435,661.20
      580,881.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report